Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uri-weg study: fosfomycin versus nitrofurantoin for cystitis in Dutch risk groups
NL-OMON45847Phase 4Recruiting
- Sponsor
- Regional Public Health Laboratory Kennemerland
- Start
- Oct 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cystitis and urinary tract infection (UTI) comparing Fosfomycin with Nitrofurantoin (2 arms). Primary endpoint: Microbiological effectiveness. Started Oct 2016; status: recruiting.
02
Drugs
fosfomycinnitrofurantoin
03
Conditions
cystitisurinary tract infection (UTI)
Beyond the preview
Go deeper on NL-OMON45847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45847.